Transmission barrier of the <i>bla</i>KPC plasmid mediated by type I restriction-modification systems in <i>Escherichia coli</i>
Dan Li(Fudan University), Minggui Wang(Fudan University), Xiaogang Xu(Fudan University), Xiaoying Jiang(Hangzhou Normal University), Mingjia Peng(Fudan University), Minghua Wang(Fudan University), Dongliang Wang(Gansu Provincial Hospital), Pei Li(The University of Texas at El Paso), Qinglan Guo(Fudan University), Yuan Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoyu Zhao(Inner Mongolia University)
Cited by 13
Related Papers
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
An integrated gene catalog and over 10,000 metagenome-assembled genomes from the gastrointestinal microbiome of ruminants
|Microbiome|2021|334
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Emerging Plasmid-Mediated Quinolone Resistance Associated with the <i>qnr</i> Gene in <i>Klebsiella pneumoniae</i> Clinical Isolates in the United States
|Antimicrobial Agents and Chemotherapy|2004|239
Mechanisms underlying the therapeutic effects of Qingfeiyin in treating acute lung injury based on GEO datasets, network pharmacology and molecular docking
|Computers in Biology and Medicine|2022|206